Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Response and adherence to nilotinib in daily practice
NL-OMON41699Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of nilotinib, sponsored by Amsterdam University Medical Center. Started May 2013; status: active, not recruiting.
02
Drugs
nilotinib
Beyond the preview
Go deeper on NL-OMON41699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41699.